N-acetylcysteine has been shown in a randomized controlled trial to improve transplant-free survival in non–acetaminophen-related acute liver failure in patients with grade I or II hepatic encephalopathy
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p2727
Summary
| status | not read | | reprioritisations | |
|---|
| last reprioritisation on | | | suggested re-reading day | |
|---|
| started reading on | | | finished reading on | |
|---|
Details